• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVES Back to Search Results
Model Number PVS23
Device Problems Collapse (1099); Perivalvular Leak (1457); Inadequacy of Device Shape and/or Size (1583); Insufficient Information (3190)
Patient Problems No Known Impact Or Consequence To Patient (2692); No Information (3190)
Event Date 12/02/2019
Event Type  Injury  
Manufacturer Narrative
Device location not presently known.
 
Event Description
On (b)(6) 2019, a patient received a perceval pvs23 in aortic position.The device was explanted intraoperatively and replaced with a magna ease size 21.No other information on the reason for the explant is presently available.
 
Event Description
On (b)(6) 2019, a patient received a perceval pvs23 in aortic position.The device was explanted intraoperatively and replaced with a magna ease size 21.Per additional information received, the perceval valve was initially oversized.When weaning from bypass, a perivalvular leak was noted and a stent folding was identified.The surgeon explanted the device and decided to continue the procedure with a sewed valve.No perceived issue with the explanted pvs23 was reported.A good outcome for the patient is reported, who was discharged home and doing well.
 
Manufacturer Narrative
The manufacturing and material records for the perceval heart valve, model #icv1209, s/n # (b)(6), as they pertain to the reported event, were retrieved and reviewed by quality engineering.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1209) perceval heart valve at the time of manufacture and release.Since the device was discarded, no further investigation is possible at this time.Based on the available information, the root cause of the reported event can be reasonably traced to an initial oversizing of the perceval valve as also confirmed from the information reported from the field, which is in line with livanova clinical experience.Should additional information be provided on this event, a follow-up report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVES
Manufacturer (Section D)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, british columbia
MDR Report Key9528761
MDR Text Key177995136
Report Number3004478276-2019-00344
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000429
UDI-Public(01)00896208000429(240)ICV1209(17)201018
Combination Product (y/n)N
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 01/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/29/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/18/2020
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received01/01/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-